McMaster Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
Can J Anaesth. 2023 Jun;70(6):1064-1074. doi: 10.1007/s12630-023-02462-x. Epub 2023 May 12.
The under-representation of Black people within critical care research limits the generalizability of randomized controlled trials (RCTs). This meta-epidemiologic study investigated the proportionate representation of Black people enrolled at USA and Canadian study sites from high impact critical care RCTs.
We searched for critical care RCTs published in general medicine and intensive care unit (ICU) journals between 1 January 2016 and 31 December 2020. We included RCTs that enrolled critically ill adults at USA or Canadian sites and provided race-based demographic data by study site. We compared study-based racial demographics with site-level city-based demographics and pooled representation of Black people across studies, cities, and centres using a random effects model. We used meta-regression to explore the impact of the following variables on Black representation in critical care RCTs: country, drug intervention, consent model, number of centres, funding, study site city, and year of publication.
We included 21 eligible RCTs. Of these, 17 enrolled at only USA sites, two at only Canadian sites, and two at both USA and Canadian sites. Black people were under-represented in critical care RCTs by 6% compared with population-based city demographics (95% confidence interval, 1 to 11). Using meta-regression, after controlling for pertinent variables, the country of the study site was the only significant source of heterogeneity (P = 0.02).
Black people are under-represented in critical care RCTs compared with site-level city-based demographics. Interventions are required to ensure adequate Black representation in critical care RCTs at both USA and Canadian study sites. Further research is needed to investigate the factors contributing to Black under-representation in critical care RCTs.
在重症监护研究中,黑人的代表性不足限制了随机对照试验(RCT)的普遍性。本项荟萃流行病学研究调查了美国和加拿大研究点的高影响力重症监护 RCT 中入组的黑人比例。
我们搜索了 2016 年 1 月 1 日至 2020 年 12 月 31 日期间发表在普通医学和重症监护病房(ICU)期刊上的重症监护 RCT。我们纳入了在美加研究点入组危重症成人的 RCT,并按研究点提供基于种族的人口统计学数据。我们使用随机效应模型比较了基于研究的种族人口统计学数据与基于地点的城市人口统计学数据,并对研究、城市和中心的黑人代表性进行了汇总。我们使用荟萃回归来探讨以下变量对重症监护 RCT 中黑人代表性的影响:国家、药物干预、同意模式、中心数量、资金、研究点城市和发表年份。
我们纳入了 21 项符合条件的 RCT。其中,17 项仅在美国开展,2 项仅在加拿大开展,2 项在美国和加拿大均开展。与基于人群的城市人口统计学数据相比,重症监护 RCT 中黑人的代表性不足 6%(95%置信区间,1 至 11)。使用荟萃回归,在控制了相关变量后,研究点所在国家是唯一显著的异质性来源(P = 0.02)。
与基于地点的城市人口统计学数据相比,重症监护 RCT 中黑人的代表性不足。需要采取干预措施,以确保在美国和加拿大研究点的重症监护 RCT 中黑人有足够的代表性。需要进一步研究导致重症监护 RCT 中黑人代表性不足的因素。